Clik here to view.
Jefferies to Lead Urgent Initiative to Raise up to $1 Billion in Private...
NEW YORK Jefferies Financial Group, Inc. (NYSE: JEF) today announced it is the first private-sector company to support a newly established public-private consortium launched by the U.S. Department...
View ArticleClik here to view.
KYOCERA to Acquire Japan-Based Showa Optronics Co., Ltd. to Strengthen...
KYOTO, Japan Kyocera Corporation (President: Hideo Tanimoto; hereunder: Kyocera) today announced that it entered into a share transfer agreement with NEC Corporation (President: Takashi Niino;...
View ArticleClik here to view.
ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the approval of ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody...
View ArticleClik here to view.
Inzomelid completes Phase I studies and shows positive results in the...
DUBLIN & CAMBRIDGE, England & BRISBANE, Australia Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple drugs that stop harmful inflammation, today...
View ArticleClik here to view.
Lumos Diagnostics Supports the Victorian Healthcare System by Providing...
SARASOTA, Fla. & MELBOURNE, Australia Lumos Diagnostics and Planet Innovation, its strategic investor and partner, have mobilized a philanthropic effort to provide the FebriDx® diagnostic test...
View ArticleClik here to view.
Physiology SimViz.ai Pioneer Zenerchi Announces Coronavirus Initiative, New...
SALT LAKE CITY Life extension and biomedical simulation and visualization AI company Zenerchi™ LLC (www.SimViz.ai) today announced it has leveraged its platform to create educational and...
View ArticleClik here to view.
针对COVID-19所致的血液短缺，Masimo提供rainbow®无创血液成分监测许可证，包括总血红蛋白、SpHb®，在冠状病毒大流行期间无需额外付费
加州尔湾 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，为应对当前冠状病毒大流行导致的全球范围血液短缺，该公司正向使用rainbow®就绪器械的医院免费提供rainbow®许可证。Masimo...
View ArticleClik here to view.
Poxel Reports Financial Results for Full Year 2019 and Provides Corporate Update
LYON, France The management team will host a conference call today, Thursday, March 26th in English at 2:30 pm EDT (New York time) / 7:30 pm CET (Paris time). A presentation will be available in the...
View ArticleClik here to view.
CG Oncology Announces License and Commercialization Agreement with Kissei...
IRVINE, Calif. CG Oncology, Inc. has announced today an exclusive license, development and commercialization agreement with Kissei Pharmaceutical Co., Ltd. (“Kissei”) for its oncolytic immunotherapy...
View ArticleClik here to view.
Ubiquitome’s COVID-19 Fast Test Device in Spotlight
AUCKLAND, New Zealand Ubiquitome’s ability to deliver fast test results for COVID-19 is attracting global inquires and top talent keen to get it to countries in desperate need. Dr Paul Pickering,...
View ArticleClik here to view.
ExThera的Affinity血液过滤器用于治疗COVID-19患者
加州马丁内斯 (美国商业资讯)–德国和意大利的医院已开始用ExThera的Seraph®100 Microbind® Affinity血液过滤器(Seraph 100)治疗COVID-19。法国和美国预计也将很快开始使用Seraph 100治疗COVID-19。 Seraph 100是唯一获准用于减少血液中病原体的“血液灌流器械”。在最近的欧盟临床病例中，Seraph...
View ArticleClik here to view.
GN MEDI Antibacterial Spray Launched to End COVID-19 Crisis and Solve the...
SEOUL, South Korea Ventex launched GN MEDI 99.9% antibacterial spray which is an eco-friendly and odorless product containing harmless minerals for sterilization and disinfection. The product is...
View ArticleClik here to view.
CDISC Launches Task Force to Rapidly Develop Standards for COVID-19
AUSTIN, Texas CDISC has launched a task force to rapidly develop guidance on standardizing COVID-19 research data with the participation of several member companies. This guidance will be released...
View ArticleClik here to view.
Dassault Systèmes Solutions Supporting Simulation and Prevention of...
VELIZY-VILLACOUBLAY, France In accordance with its new strategic direction “From Things to Life,” Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today announced that it is working...
View ArticleClik here to view.
エクステラのアフィニティー血液フィルターをCOVID-19患者の治療に使用
米カリフォルニア州マーティネズ （ビジネスワイヤ） — エクステラ（ExThera）のアフィニティー血液フィルターSeraph®100 Microbind®（Seraph 100）を使用して、COVID-19の治療がドイツとイタリアの病院で開始されました。Seraph 100によるCOVID-19治療はフランスと米国でも間もなく開始される見込みです。 Seraph...
View ArticleClik here to view.
Daiichi Sankyo Submits Application for CAR T Therapy Axicabtagene Ciloleucel...
TOKYO & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labour...
View ArticleClik here to view.
Clik here to view.
Aptorum Group Limited Corporate Update and To Hold Q1 2020 Investor Update...
NEW YORK Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today provides an...
View ArticleClik here to view.
PreCheck Announces Exclusive Distribution Agreements for Coronavirus...
DENISON, Texas PreCheck Health Services, Inc. (OTC PINK: HLTY), a distributor of medical screening devices for use by physicians in managing a patient’s health, announces it has entered into a new...
View ArticleClik here to view.
Bionomics and MSD Scientists Publish Preclinical Findings for BNC375 in...
ADELAIDE, Australia Bionomics Limited (ASX: BNO, OTCQB:BNOEF), a global, clinical stage biopharmaceutical company, today announced that a paper describing the pharmacology of BNC375, a novel...
View Article